An investigation into the characteristics of chitosan/Kollicoat SR30D free films for colonic drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 72, Issue 1, 2009, Pages 266-274

  Wei, He ^a,b   Li Fang, Fan ^a   Bai, Xiang ^a   Chun Lei, Li ^b   Qing, Du ^a   Yong Zhen, Chang ^a   De Ying, Cao ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b CSPC Pharmaceutical Technology Co Ltd   (China)

Author keywords

Chitosan; Colonic drug delivery; Kollicoat SR30D; Mixed film; Permeability

Indexed keywords

BETA GLUCOSIDASE; CHITOSAN; DRUG VEHICLE; KOLLICOAT; SR 30D; UNCLASSIFIED DRUG;

ARTICLE; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PACKAGING; DRUG PENETRATION; FILM COATING; PHYSICAL CHEMISTRY; TEMPERATURE DEPENDENCE; THERMOGRAVIMETRY;

ANIMALS; BETA-GLUCOSIDASE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLON; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; POLYVINYLS; RATS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; THERMOGRAVIMETRY;

EID: 62949160307     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.10.017     Document Type: Article

References (47)

1. Basit A.W. Advances in colonic drug delivery. Drugs 65 14 (2005) 1991-2007
2. Friend D.R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 2 (2005) 247-265
3. Fadda H.M., and Basit A.W. Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers. J. Drug Del. Sci. Tech. 15 (2005) 273-279
4. Jack A., Naresh T., and Vinayak P. Colonic drug delivery challenges and opportunities - an overview. Eur. Gastroenterol. Rev. (Current issues) (2006) 1-5
5. Sinha V.R., and Kumria R. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci. 18 (2003) 3-18
6. Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv. Drug Deliv. Rev. 56 4 (2004) 491-509
7. Yang L. Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora. J. Control. Release 125 (2008) 77-86
8. McConnell E.L., Short M.D., and Basit A.W. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J. Control. Release 130 (2008) 154-160
9. Hawksworth G., Drasar B.S., and Hill M.J. Intestinal bacteria and hydrolysis of glycosidic bonds. J. Med. Microbiol. 4 (1971) 451
10. Rowland I.R. Drug Metabolism Reviews (1988), Marcel Dekker, New York
11. Larsen C., Harboe E., Johansen M., and Olesen H.P. Macromolecular prodrugs. XVI. Colon-targeted delivery - comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract. Pharm. Res. 6 12 (1989) 995-999
12. McLeod A.D., Friend D.R., and Tozer T.N. Synthesis and chemical stability of glucocorticoiddextran esters, potential prodrugs for colonspecific delivery. Int. J. Pharmacol. 92 (1993) 105
13. Furda I. In: Furda I. (Ed). Aminopolysaccharides-their Potential as Dietary Fiber (1983), American Chemical Society, Washington, DC 105-122
14. Omrod D.J., Holmes C.C., and Miller T.E. Dietary chitosan inhibits hypercholesterolaemia and antherogensis in the apoliprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138 (1998) 329-334
15. Chourasia M.K., and Jain S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6 1 (2003) 33-66
16. McConnell E.L., Murdan S., and Basit A.W. An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria. J. Pharm. Sci. 97 (2008) 3820-3829
17. Knapczyk J., Krowczynski L., Pawlik B., and Liber Z. In: Skjak-Braek G., Anthonsen T., and Sandford P. (Eds). Chemistry, Biochemistry, Physical Properties and Applications (1984), Elsevier, London 665
18. S. Hirano, H. Seino, Y. Akiyama, I. Nonaka, in: C.G. Gebelein, R.L. Dunn (Eds.), Plenum Press, New York, 1990, p. 283.
19. Struszczyk H., Wawro D., and Niekraszewicz A. In: Brine C.J., Sandford P.A., and Zikakis J.P. (Eds). Advances in Chitin and Chitosan (1991), Elsevier, London 580
20. Amiji M.M. Permeability and blood compatibility properties of chitosan-poly (ethylene oxide) blend membranes for haemodialysis. Biomaterials 16 8 (1995) 593-599
21. Qureshi M.T., Blair H.S., and Allen S.J. Studies on modified chitosan membranes. II. Dialysis of low molecular weight metabolites. J. Appl. Polym. Sci. 46 (1992) 263-269
22. Sinha V.R., and Kumria R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224 1-2 (2001) 19-38
23. Liu L.S., Fishman M.L., Kost J., and Hicks K.B. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 24 19 (2003) 3333-3343
24. Oosegi T., Onishi H., and Machida Y. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Int. J. Pharm. 348 1-2 (2008) 80-88
25. Margulis E.B., and Moustafine R.I. Swellability testing of chitosan/Eudragit L100-55 interpolyelectrolyte complexes for colonic drug delivery. J. Control. Release 116 2 (2006) 36-37
26. Ghaffari A., Navaee K., Oskoui M., Bayati K., and Rafiee-Tehrani M. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: Preparation and evaluation. Acta Pharm. 56 (2006) 299-310
27. A. Dashevsky, A. Krause, K. Kolter, R. Bodmeier, Compaction of pellets coated with a new aqueous poly-mer dispersion, Kollicoat SR 30 D., AAPS Annual Meeting Supplement., vol. 2, AAPS PharmSci. Available from: , 2000.
28. Kolter K., and Ruchatz F. Kollicoat SR 30D - A new sustained-release excipient. Proc. Int. Symp. Control. Release Bioact. Mater. 26 (1999) 6311
29. Shao Z.J., Moralesi L., Diaz S., and Muhammadi N.A. Drug release from Kollicoat SR 30D-coated nonpareil beads: evaluation of coating level, plasticizer type, and curing condition. AAPS PharmSciTech 3 2 (2002) E15
30. Dashevsky A., Wagner K., Kolter K., and Bodmeier R. Physicochemical and release properties of pellets coated with Kollicoat SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release. Int. J. Pharm. 290 1-2 (2005) 15-23
31. Hejazi R., and Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 89 2 (2003) 151-165
32. Bodmeier R., and Paerataku O. Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms. Pharm. Res. 11 (1994) 882-888
33. Van den Mooter G., Samyn C., and Kinget R. Characterization of colon-specific azo polymers: a study of the swelling properties and permeability of isolated polymers films. Int. J. Pharm. 111 (1994) 127-136
34. Blanchon S., Couarraze G., Rieg-Falson F., Cohen G., and Puisieux F. Permeability of progesterone and a synthetic progestin through methacrylic films. Int. J. Pharm. 72 (1991) 1-10
35. He W., Du Q., Cao D.Y., Xiang B., and Fan L.F. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int. J. Pharm. 348 1-2 (2008) 35-45
36. Nunthanid J., Huanbutta K., Luangtana-Anan M., Sriamornsak P., Limmatvapirat S., and Puttipipatkhachorn S. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose. Eur. J. Pharm. Biopharm. 68 2 (2008) 253-259
37. Flynn G.L., Yalkowsky S.H., and Roseman T.J. Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 63 (1974) 479-509
38. Okhamafe A.O., and York P. Studies of interaction phenomena in aqueous-based film coatings containing soluble additives using thermal analysis techniques. J. Pharm. Sci. 77 5 (1988) 438-443
39. Felton L.A. Characterization of coating systems. AAPS PharmSciTech 8 4 (2007) E112
40. Macleod G.S., Fell J.T., and Collett J.H. Studies on the physical properties of mixed pectin/ethylcellulose films intended for colonic drug delivery. Int. J. Pharm. 157 (1997) 53-60
41. Siew L.F., Basit A.W., and Newton J.M. The properties of amylose-ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. Eur. J. Pharm. Sci. 11 2 (2000) 133-139
42. He W., Du Q., Cao D.Y., Xiang B., and Fan L.F. Selective drug delivery to the colon using pectin coated pellets. PDA J. Phram. Sci. Technol. 62 4 (2008) 264-272
43. Langer R.S., and Peppas N.A. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2 (1981) 201-214
44. Finegold S.M., Sutter V.L., Sugihara P.T., Elder H.A., Lehmann S.M., and Phillips R.L. Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am. J. Clin. Nutr. 30 11 (1977) 1781-1792
45. Gamelin E., Boisdron-Celle M., Delva R., Regimbeau C., Cailleux P.E., and Alleaume C. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. J. Clin. Oncol. 16 (1998) 1470-1478
46. A.A. Salyers, J.A. Leedle, in: D. J. Hentge (Ed.), Academic Press, New York, 1983, pp. 129-146.
47. Tarvainen M., Sutinen R., Peltonen S., Tiihonen P., and Paronen P. Starch acetate - a novel film-forming polymer for pharmaceutical coatings. J. Pharm. Sci. 91 1 (2002) 282-289